The Danish multiple sclerosis treatment register
Research output: Contribution to journal › Review › Research › peer-review
Aim of the database: The Danish Multiple Sclerosis Treatment Register (DMSTR) serves as a clinical quality register, enabling the health authorities to monitor the quality of the diseasemodifying treatment, and it is an important data source for epidemiological research. Study population: The DMSTR includes all patients with multiple sclerosis who had been treated with disease-modifying drugs since 1996. At present, more than 8,400 patients have been registered in this database. Data are continuously entered online into a central database from all sites in Denmark at start and at regular visits. Main variables: Include age, sex, onset year and year of the diagnosis, basic clinical information, and information about treatment, side effects, and relapses. Descriptive data: Notification is done at treatment start, and thereafter at every scheduled clinical visit 3 months after treatment start, and thereafter every 6 months. The longitudinally collected information about the disease activity and side effects made it possible to investigate the clinical efficacy and adverse events of different disease-modifying therapies. Conclusion: The database contributed to a certain harmonization of treatment procedures in Denmark and will continue to be a major factor in terms of quality in clinical praxis, research and monitoring of adverse events, and plays an important role in research.
Original language | English |
---|---|
Journal | Clinical Epidemiology |
Volume | 8 |
Pages (from-to) | 549-552 |
Number of pages | 4 |
ISSN | 1179-1349 |
DOIs | |
Publication status | Published - 25 Oct 2016 |
- Disease modifying therapy, Epidemiology, Immunomodulatory treatment, Multiple sclerosis, Neutralizing antibodies, Observational studies, Registry research
Research areas
ID: 179214827